Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Outcomes of Older Patients (≥60 years) with New-Onset Idiopathic Nephrotic Syndrome Receiving Immunosuppressive Regimen: A Multicentre Study of 116 Patients.

Colliou E, Karras A, Boffa JJ, Ribes D, Garrouste C, Quintrec ML, Daugas E, Huart A, Ducloux D, Hummel A, Ferrandiz I, Demoulin N, Jourde-Chiche N, Chauveau D, Audard V, Faguer S.

J Clin Med. 2019 Mar 2;8(3). pii: E298. doi: 10.3390/jcm8030298.

2.

The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.

Maas RJ, Deegens JK, Beukhof JR, Reichert LJ, Ten Dam MA, Beutler JJ, van den Wall Bake AWL, Rensma PL, Konings CJ, Geerse DA, Feith GW, Van Kuijk WH, Wetzels JF.

Am J Kidney Dis. 2017 May;69(5):637-646. doi: 10.1053/j.ajkd.2016.10.032. Epub 2017 Jan 12.

PMID:
28089478
4.

Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.

Stokes MB, Markowitz GS, Lin J, Valeri AM, D'Agati VD.

Kidney Int. 2004 May;65(5):1690-702.

5.

Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood.

Skrzypczyk P, Panczyk-Tomaszewska M, Roszkowska-Blaim M, Wawer Z, Bienias B, Zajgzkowska M, Kilis-Pstrusinska K, Jakubowska A, Szczepaniak M, Pawlak-Bratkowska M, Tkaczyk M.

Clin Nephrol. 2014 Mar;81(3):166-73. doi: 10.5414/CN108044.

PMID:
24361057
6.

Idiopathic Nephrotic Syndrome: Characteristics and Identification of Prognostic Factors.

Dumas De La Roque C, Prezelin-Reydit M, Vermorel A, Lepreux S, Deminière C, Combe C, Rigothier C.

J Clin Med. 2018 Sep 9;7(9). pii: E265. doi: 10.3390/jcm7090265.

7.

Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).

Yokoyama H, Sugiyama H, Narita I, Saito T, Yamagata K, Nishio S, Fujimoto S, Mori N, Yuzawa Y, Okuda S, Maruyama S, Sato H, Ueda Y, Makino H, Matsuo S.

Clin Exp Nephrol. 2015 Jun;19(3):496-505. doi: 10.1007/s10157-014-1022-x. Epub 2014 Sep 18.

PMID:
25230687
8.

[Instructions and implementations for percutaneous renal biopsy. Guidelines for the therapy of glomerular nephropaties].

Cagnoli L; Italian Society of Nephrology.

G Ital Nefrol. 2003 Sep-Oct;20 Suppl 24:S3-47. Review. Italian.

PMID:
14666502
9.

Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.

El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.

Nephrol Dial Transplant. 2005 Nov;20(11):2433-8. Epub 2005 Oct 4.

PMID:
16204303
10.

Rituximab for Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome in Adults: A Retrospective, Multicenter Study in Spain.

DaSilva I, Huerta A, Quintana L, Redondo B, Iglesias E, Draibe J, Praga M, Ballarín J, Díaz-Encarnación M; Spanish Group for the Study of Glomerular Diseases (GLOSEN).

BioDrugs. 2017 Jun;31(3):239-249. doi: 10.1007/s40259-017-0221-x.

PMID:
28534103
11.

[Management of idiopathic nephrotic syndrome in childhood].

Peco-Antić A.

Srp Arh Celok Lek. 2004 Sep-Oct;132(9-10):352-9. Review. Serbian.

12.

A randomized study on a 3-month versus a 7-month prednisolone regimen for the initial episode of childhood idiopathic nephrotic syndrome at a large Saudi center.

Al Talhi A, Al Saran K, Osman ET, Al Shatri A, Osman M, Mirza K.

Int J Pediatr Adolesc Med. 2018 Mar;5(1):18-23. doi: 10.1016/j.ijpam.2017.12.004. Epub 2018 Feb 18.

13.

Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome.

Sinha A, Bhatia D, Gulati A, Rawat M, Dinda AK, Hari P, Bagga A.

Nephrol Dial Transplant. 2015 Jan;30(1):96-106. doi: 10.1093/ndt/gfu267. Epub 2014 Aug 13.

PMID:
25121488
14.

Rituximab in adult minimal change disease and focal segmental glomerulosclerosis.

Kronbichler A, Bruchfeld A.

Nephron Clin Pract. 2014;128(3-4):277-82. doi: 10.1159/000368590. Epub 2014 Nov 8. Review.

15.

Long-term Outcome of Adult Onset Idiopathic Minimal Change Disease.

Colattur SN, Korbet SM.

Saudi J Kidney Dis Transpl. 2000 Jul-Sep;11(3):334-44.

16.

Cyclophosphamide in the treatment of focal segmental glomerulosclerosis.

Martinelli R, Pereira LJ, Silva OM, Okumura AS, Rocha H.

Braz J Med Biol Res. 2004 Sep;37(9):1365-72. Epub 2004 Aug 24.

17.

Childhood nephrotic syndrome in tropical Africa: then and now.

Olowu WA, Ademola A, Ajite AB, Saad YM.

Paediatr Int Child Health. 2017 Nov;37(4):259-268. doi: 10.1080/20469047.2017.1374002. Epub 2017 Sep 26. Review.

PMID:
28949280
18.

Acute kidney injury in idiopathic nephrotic syndrome of childhood is a major risk factor for the development of chronic kidney disease.

Yaseen A, Tresa V, Lanewala AA, Hashmi S, Ali I, Khatri S, Mubarak M.

Ren Fail. 2017 Nov;39(1):323-327. doi: 10.1080/0886022X.2016.1277743.

19.

Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab.

Kamei K, Ishikura K, Sako M, Aya K, Tanaka R, Nozu K, Kaito H, Nakanishi K, Ohtomo Y, Miura K, Takahashi S, Morimoto T, Kubota W, Ito S, Nakamura H, Iijima K; Rituximab for Childhood-Onset Refractory Nephrotic Syndrome (RCRNS) Study Group.

Pediatr Nephrol. 2017 Nov;32(11):2071-2078. doi: 10.1007/s00467-017-3718-0. Epub 2017 Jun 29.

PMID:
28664242
20.

Histopathological spectrum of childhood nephrotic syndrome in Indian children.

Kumar J, Gulati S, Sharma AP, Sharma RK, Gupta RK.

Pediatr Nephrol. 2003 Jul;18(7):657-60. Epub 2003 May 13.

PMID:
12743793

Supplemental Content

Support Center